Evidence map›Paper›PMID 25838980›Full record

ArticleTissue barriers2015

Cytoskeletal mechanisms regulating vascular endothelial barrier function in response to acute lung injury.

Anita Kása, Csilla Csortos, Alexander D Verin

Open access · bronzeAbstract read
In one paragraph

Article in Tissue barriers, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 111 citations in OpenAlex.

  1. Octreotide Counteracts IFN-γ-Induced Endothelial Inflammation.Journal of biochemical and molecular toxicology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Anita KásaVascular Biology Center; Georgia Regents University ; Augusta, GA USA.
Csilla CsortosDepartment of Medical Chemistry; Faculty of Medicine; University of Debrecen ; Debrecen, Hungary.
Alexander D VerinVascular Biology Center; Georgia Regents University ; Augusta, GA USA ; Division of Pulmonary; Medicine Medical College of Georgia; Georgia Regents University; Augusta, GA USA.
Georgia Regents Medical Center · USUniversity of Debrecen · HU

Funding

Therapeutic Mechanisms of RhoA Inhibition In Acute Lung InjuryP01HL101902 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2011 to 2016
$11.2M
NHLBI NIH HHS P01 HL101902
6 · The paper itself

Abstract

Endothelial cells (EC) form a semi-permeable barrier between the interior space of blood vessels and the underlying tissues. In acute lung injury (ALI) the EC barrier is weakened leading to increased vascular permeability. It is widely accepted that EC barrier integrity is critically dependent upon intact cytoskeletal structure and cell junctions. Edemagenic agonists, like thrombin or endotoxin lipopolysaccharide (LPS), induced cytoskeletal rearrangement, and EC contractile responses leading to disruption of intercellular contacts and EC permeability increase. The highly clinically-relevant cytoskeletal mechanisms of EC barrier dysfunction are currently under intense investigation and will be described and discussed in the current review.

Indexed as

acute lung injuryAJ, adherens junctionALI, Acute Lung InjuryARDS, Acute Respiratory Distress Syndromebarrier functionCaD, caldesmonCPI-17, PKC potentiated inhibitory protein of 17 kDacytoskeletonEC, endothelial cellsendothelial junctionsGJ, gap junctionHSP-27, small heat shock actin-capping protein of 27 kDaIL, interleukinLPS, lipopolysaccharideMLCK, Ca2+/calmodulin (CaM) dependent MLC kinaseMLC, myosin light chainMLCP, myosin light chain phosphataseMT, microtubulesMYPT1, myosin phosphatase targeting subunit 1PKA, protein kinase APKC, protein kinase Cpulmonary endotheliumSM, smooth musclethrombinTJ, tight junctionTLR4, toll-like receptor 4TNFα, tumor necrosis factor α

Identifiers

PMID25838980
PMCPMC4372017
OpenAlexW2007272589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.